Works matching DE "IRBESARTAN"
Results: 209
Sparsentan in immunoglobulin A nephropathy: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2024, v. 40, n. 3, p. 101, doi. 10.1007/s40267-024-01058-9
- By:
- Publication type:
- Article
Late-Onset Anaphylaxis due to Irbesartan.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Journal scan.
- Published in:
- Asian Journal of Pediatric Nephrology, 2023, v. 6, n. 2, p. 70, doi. 10.4103/ajpn.ajpn_22_23
- By:
- Publication type:
- Article
DISPERSIVE LIQUID LIQUID MICRO EXTRACTION SPECTROPHOTOMETRIC DETERMINATION OF TELMESARTAN AND IRBESARTAN IN PHARMACEUTICALS SAMPLES.
- Published in:
- Iraq Journal of Market Research & Consumer Protection / Al-Mağallaẗ al-ʿIrāqiyyaẗ li-Buḥūṯ al-Sūq wa-Ḥimāyaẗ al-Mustahlik, 2020, v. 12, n. 2, p. 153
- By:
- Publication type:
- Article
Effect of pH on the complexation of irbesartan withβ -, hydroxypropyl-β -, and γ-cyclodextrin: solubility enhancement and physicochemical characterization.
- Published in:
- Turkish Journal of Chemistry, 2018, v. 42, n. 6, p. 1544, doi. 10.3906/kim-1805-22
- By:
- Publication type:
- Article
Understanding the molecular-pharmaceutical basis of sartan recalls focusing on valsartan.
- Published in:
- Global Cardiology Science & Practice, 2020, v. 2020, n. 2, p. 1, doi. 10.21542/gcsp.2020.25
- By:
- Publication type:
- Article
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study.
- Published in:
- Diabetic Medicine, 2021, v. 38, n. 9, p. 1, doi. 10.1111/dme.14405
- By:
- Publication type:
- Article
NEPHROTIC PROTEINURIA AND HYPERTENSION.
- Published in:
- Nephrology, 2010, v. 15, n. 4, p. 502, doi. 10.1111/j.1440-1797.2010.01207.x
- By:
- Publication type:
- Article
Effect of Home Blood Pressure Monitoring on Patient’s Awareness and Goal Attainment Under Antihypertensive Therapy: The Factors Influencing Results in Anti-HypertenSive Treatment (FIRST) Study.
- Published in:
- Kidney & Blood Pressure Research, 2018, v. 43, n. 3, p. 979, doi. 10.1159/000490687
- By:
- Publication type:
- Article
FORMULATION AND EVALUATION OF IRBESARTAN LOADED SOLID LIPID NANOPARTICLES BY SOLVENT INJECTION METHOD.
- Published in:
- Pharma Science Monitor, 2015, v. 6, n. 1, p. 159
- By:
- Publication type:
- Article
Blood Pressure Response to Zofenopril or Irbesartan Each Combined with Hydrochlorothiazide in High-Risk Hypertensives Uncontrolled by Monotherapy: A Randomized, Double-Blind, Controlled, Parallel Group, Noninferiority Trial.
- Published in:
- International Journal of Hypertension, 2015, v. 2015, p. 1, doi. 10.1155/2015/139465
- By:
- Publication type:
- Article
Irbesartan ameliorates inflammation via transendothelial leukocyte migration due to VCAM-1/NOX-1 signaling in cisplatin-induced cardiotoxicity.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2023, v. 26, n. 11, p. 1298, doi. 10.22038/IJBMS.2023.70997.15422
- By:
- Publication type:
- Article
BIOEQUIVALENCE STUDY OF A FIXED DOSE COMBINATION OF IRBESARTAN/ AMLODIPINE/HYDROCHLOROTHIAZIDE FILM COATED TABLET MANUFACTURED IN TURKEY.
- Published in:
- Nobel Medicus Journal, 2014, v. 10, n. 3, p. 24
- By:
- Publication type:
- Article
Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria.
- Published in:
- Diabetes Care, 2011, v. 34, n. 5, p. 1192, doi. 10.2337/dc10-2214
- By:
- Publication type:
- Article
Renal Effects of Aliskiren Compared With and in Combination With Irbesartan in Patients With Type 2 Diabetes, Hypertension, and Albuminuria.
- Published in:
- Diabetes Care, 2009, v. 32, n. 10, p. 1873, doi. 10.2337/dc09-0168
- By:
- Publication type:
- Article
The first description of mucous membrane pemphigoid induced by enalapril maleate: a case report.
- Published in:
- BMC Oral Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12903-024-04865-8
- By:
- Publication type:
- Article
Treatment of 5/6 nephrectomy rats with sulodexide: a novel therapy for chronic renal failure.
- Published in:
- Acta Pharmacologica Sinica, 2012, v. 33, n. 5, p. 644, doi. 10.1038/aps.2012.2
- By:
- Publication type:
- Article
Synergism of irbesartan and amlodipine on hemodynamic amelioration and organ protection in spontaneously hypertensive rats.
- Published in:
- Acta Pharmacologica Sinica, 2011, v. 32, n. 9, p. 1109, doi. 10.1038/aps.2011.88
- By:
- Publication type:
- Article
Irbesartan decreased mitochondrial stress related apoptosis in cisplatin induced acute kidney injury via regulating BCL-2/BAX signaling.
- Published in:
- Molecular Biology Reports, 2022, v. 49, n. 7, p. 6125, doi. 10.1007/s11033-022-07403-3
- By:
- Publication type:
- Article
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET).
- Published in:
- Cardiology Research Review, 2021, n. 96, p. 3
- By:
- Publication type:
- Article
Voltammetric Detection of Irbesartan by Molecularly Imprinted Polymer (MIP)-Modified Screen-Printed Electrodes.
- Published in:
- Chemosensors, 2022, v. 10, n. 12, p. 517, doi. 10.3390/chemosensors10120517
- By:
- Publication type:
- Article
Comparison of clinical efficacy of metoprolol combined with irbesartan and hydrochlorothiazide and non-invasive ventilator in the emergency treatment of patients with severe heart failure.
- Published in:
- Experimental & Therapeutic Medicine, 2018, v. 16, n. 6, p. 5059, doi. 10.3892/etm.2018.6828
- By:
- Publication type:
- Article
Therapeutic effect of irbesartan combined with atorvastatin calcium in the treatment of rats with coronary heart disease.
- Published in:
- Experimental & Therapeutic Medicine, 2018, v. 16, n. 5, p. 4119, doi. 10.3892/etm.2018.6669
- By:
- Publication type:
- Article
Radioiodination and biological evaluation of irbesartan as a tracer for cardiac imaging.
- Published in:
- Radiochimica Acta, 2021, v. 109, n. 1, p. 41, doi. 10.1515/ract-2020-0025
- By:
- Publication type:
- Article
THE PROCESS VALIDATION OF TABLET CONTAINING IRBESARTAN 300MG AND HYDROCHLOROTHIAZIDE 12.5mg.
- Published in:
- Gomal University Journal of Research, 2017, v. 33, n. 1, p. 1
- By:
- Publication type:
- Article
NOVEL HPLC STATIONARY REVERSE PHASE COMPOUND DERIVED TO VALIDATE IRBESARTAN AND ITS IMPURITIES.
- Published in:
- Rasayan Journal of Chemistry, 2019, v. 12, n. 4, p. 2141, doi. 10.31788/RJC.2019.1245419
- By:
- Publication type:
- Article
CURE ACTIVE: No Loss of Clopidogrel Efficacy with the CYP2C19 Loss-of- Function Allele in Patients with ACS or AF.
- Published in:
- MD Conference Express, 2010, p. 33, doi. 10.1177/155989771008025
- Publication type:
- Article
Irbesartan Fails to Prevent Most Vascular Events in Patients with AF.
- Published in:
- MD Conference Express, 2009, p. 12, doi. 10.1177/155989770904005
- Publication type:
- Article
New UPLC-MS/MS method for simultaneous determination of irbesartan and hydrochlorthiazide in human plasma.
- Published in:
- Journal of the Iranian Chemical Society, 2014, v. 11, n. 6, p. 1579, doi. 10.1007/s13738-014-0429-3
- By:
- Publication type:
- Article
P167 Simvastatin & irbesartan suppresses inflammatory responses, chemokine expressions and apoptosis induced by myocardial ischemia/reperfusion in male rats.
- Published in:
- Cardiovascular Research, 2014, v. 103, n. suppl_1, p. S29, doi. 10.1093/cvr/cvu082.104
- By:
- Publication type:
- Article
Irbesartan did not reduce cardio events in atrial fibrillation patients.
- Published in:
- Australian Journal of Pharmacy, 2011, v. 92, n. 1095, p. 83
- Publication type:
- Article
Protective effect of irbesartan against doxorubicin-induced nephrotoxicity in rats: implication of AMPK, PI3K/Akt, and mTOR signaling pathways.
- Published in:
- Canadian Journal of Physiology & Pharmacology, 2018, v. 96, n. 12, p. 1209, doi. 10.1139/cjpp-2018-0259
- By:
- Publication type:
- Article
The Role of Irbesartan in the Treatment of Patients with Hypertension: A Comprehensive and Practical Review.
- Published in:
- High Blood Pressure & Cardiovascular Prevention, 2012, v. 19, n. 1, p. 19, doi. 10.2165/11632100-000000000-00000
- By:
- Publication type:
- Article
Angiotensin II antagonists - an assessment of their acute toxicity.
- Published in:
- Clinical Toxicology (15563650), 2013, v. 51, n. 5, p. 429, doi. 10.3109/15563650.2013.800875
- By:
- Publication type:
- Article
Appropriate nomenclature: angiotensin II receptors.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Effect of Atorvastatin combined with Irbesartan in the treatment of early diabetic nephropathy.
- Published in:
- Pakistan Journal of Medical Sciences, 2024, v. 40, n. 7, p. 1410, doi. 10.12669/pjms.40.7.9214
- By:
- Publication type:
- Article
Clinical efficacy of linagliptin combined with irbesartan in patients with diabetic nephropathy.
- Published in:
- Pakistan Journal of Medical Sciences, 2022, v. 38, n. 1, p. 52, doi. 10.12669/pjms.38.1.4417
- By:
- Publication type:
- Article
Economic evaluation of irbesartan in combination with hydrochlorothiazide in the treatment of hypertension in Greece.
- Published in:
- European Journal of Health Economics, 2011, v. 12, n. 3, p. 253, doi. 10.1007/s10198-010-0243-5
- By:
- Publication type:
- Article
Determination of antihypertensive drugs irbesartan and doxazosin mesylate in healthcare products and urine samples using surface-enhanced Raman scattering.
- Published in:
- Analytical & Bioanalytical Chemistry, 2022, v. 414, n. 27, p. 7813, doi. 10.1007/s00216-022-04315-w
- By:
- Publication type:
- Article
Novel Synthesis and Characterization of Irbesartan Derivative an Anti‐Hypertensive Active Pharmaceutical Ingredient (API).
- Published in:
- Macromolecular Symposia, 2024, v. 413, n. 1, p. 1, doi. 10.1002/masy.202300008
- By:
- Publication type:
- Article
Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman.
- Published in:
- Medical Principles & Practice, 2013, v. 22, n. 3, p. 265, doi. 10.1159/000345389
- By:
- Publication type:
- Article
A Prospective, Multicentered, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Keluoxin Capsules in the Treatment of Microalbuminuria in Patients with Type 2 Early Diabetic Kidney Disease.
- Published in:
- Journal of Integrative & Complementary Medicine, 2024, v. 30, n. 2, p. 185, doi. 10.1089/jicm.2022.0809
- By:
- Publication type:
- Article
Adverse drug reactions: Keratoacanthoma development after systemic administration with irbesartan/hydrochlorothiaZide.
- Published in:
- Medical Review / Meditsinski Pregled, 2022, v. 58, n. 3, p. 55
- By:
- Publication type:
- Article
A SENSITIVE, ECONOMICAL BIOANALYTICAL LC-MS/MS METHOD FOR SIMULTANEOUS ANALYSIS OF IRBESARTAN AND HYDROCHLOROTHIAZIDE.
- Published in:
- Indian Drugs, 2023, v. 60, n. 6, p. 55, doi. 10.53879/id.60.06.13200
- By:
- Publication type:
- Article
HYDROTROPIC SOLUBILISATION OF IRBESARTAN: MECHANISTIC STUDY AND DISSOLUTION PROFILING.
- Published in:
- Indian Drugs, 2019, v. 56, n. 3, p. 74, doi. 10.53879/id.56.03.11612
- By:
- Publication type:
- Article
Prospective direct comparison of antihypertensive effect and safety between high-dose amlodipine or indapamide in hypertensive patients uncontrolled by standard doses of angiotensin receptor blockers and amlodipine.
- Published in:
- Clinical & Experimental Hypertension, 2018, v. 40, n. 2, p. 99, doi. 10.1080/10641963.2017.1334798
- By:
- Publication type:
- Article
Combined treatment of irbesartan and diltiazem ameliorates endothelium dependent vasodilatation in hypertensives.
- Published in:
- Clinical & Experimental Hypertension, 2017, v. 39, n. 7, p. 612, doi. 10.1080/10641963.2017.1306537
- By:
- Publication type:
- Article
Effect of single-pill irbesartan/amlodipine combination-based therapy on clinic and home blood pressure profiles in hypertension with chronic kidney diseases.
- Published in:
- Clinical & Experimental Hypertension, 2016, v. 38, n. 8, p. 744, doi. 10.1080/10641963.2016.1200063
- By:
- Publication type:
- Article
Influence of initial angiotensin receptor blockers on treatment persistence in uncomplicated hypertension: A nation-wide population-based study.
- Published in:
- Clinical & Experimental Hypertension, 2016, v. 38, n. 3, p. 325, doi. 10.3109/10641963.2015.1116548
- By:
- Publication type:
- Article
The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study
- Published in:
- Clinical & Experimental Hypertension, 2015, v. 37, n. 7, p. 542, doi. 10.3109/10641963.2015.1026037
- By:
- Publication type:
- Article